Drugs & Targets ProNAi Therapeutics and Carna Biosciences to commercialize AS-141 May 27, 2016Vol.42 No.21
Drugs & Targets CHMP Issues Positive Opinion For Kyprolis in Multiple Myeloma May 27, 2016Vol.42 No.21
Drugs & Targets Health Canada approves Imbruvica in Waldenström’s macroglobulinemia May 13, 2016Vol.42 No.19
Drugs & Targets Health Canada grants conditional approval to Ibrance in breast cancer May 13, 2016Vol.42 No.19
Drugs & Targets AbbVie and CytomX Therapeutics to collaborate on probody drug conjugates May 06, 2016Vol.42 No.18
Drugs & Targets AstraZeneca and Foundation Medicine to collaborate on diagnostic assays May 06, 2016Vol.42 No.18
